Akhila G. Wimalasingham
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
Journal: Frontiers in oncology
Published: October 03, 2022
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Journal: Cancer medicine
Published: February 19, 2021
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.
Journal: European urology oncology
Published: October 14, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy.
Journal: European urology focus
Published: December 04, 2018
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
Journal: European urology
Published: March 21, 2017
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: December 31, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026